D. E. Shaw & Co., Inc. Sarepta Therapeutics, Inc. Transaction History

D. E. Shaw & Co., Inc.

$114 Billion
Q1 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 86,866 shares of SRPT stock, worth $13.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

86,866

Previous 355,533 75.57%

Holding current value

$13.2 Million

Previous $34.3 Million 67.2%

% of portfolio

0.01%

Previous 0.03%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$93.7 - $141.53 $25.2 Million - $38 Million	-268,667 Reduced 75.57%	86,866 $11.2 Million
Q4 2023 Feb 14, 2024	BUY	$67.31 - $124.76 $17.7 Million - $32.9 Million	263,375 Added 285.79%	355,533 $34.3 Million
Q3 2023 Nov 14, 2023	SELL	$102.5 - $123.59 $18.7 Million - $22.6 Million	-182,761 Reduced 66.48%	92,158 $11.2 Million
Q2 2023 Aug 14, 2023	SELL	$106.4 - $157.19 $61.4 Million - $90.7 Million	-576,818 Reduced 67.72%	274,919 $31.5 Million
Q1 2023 May 15, 2023	BUY	$117.53 - $155.99 $31.7 Million - $42 Million	269,490 Added 46.28%	851,737 $117 Million

Q4 2022 Feb 14, 2023	SELL	$100.86 - $132.13 $5.1 Million - $6.69 Million	-50,614 Reduced 8.0%	582,247 $75.4 Million
Q3 2022 Nov 14, 2022	BUY	$75.71 - $119.24 $28.1 Million - $44.3 Million	371,378 Added 142.03%	632,861 $70 Million
Q2 2022 Aug 15, 2022	SELL	$62.69 - $88.44 $1.88 Million - $2.65 Million	-29,925 Reduced 10.27%	261,483 $19.6 Million
Q1 2022 May 16, 2022	SELL	$63.15 - $90.42 $4.21 Million - $6.03 Million	-66,687 Reduced 18.62%	291,408 $22.8 Million
Q4 2021 Feb 14, 2022	BUY	$77.28 - $99.42 $20.9 Million - $26.9 Million	270,097 Added 306.94%	358,095 $32.2 Million
Q3 2021 Nov 15, 2021	BUY	$65.97 - $92.48 $4.33 Million - $6.07 Million	65,680 Added 294.29%	87,998 $8.14 Million
Q2 2021 Aug 16, 2021	BUY	$69.38 - $86.75 $605,826 - $757,501	8,732 Added 64.27%	22,318 $1.74 Million
Q1 2021 May 17, 2021	SELL	$72.25 - $168.95 $684,496 - $1.6 Million	-9,474 Reduced 41.08%	13,586 $1.01 Million
Q4 2020 Feb 16, 2021	BUY	$125.56 - $178.74 $1.71 Million - $2.43 Million	13,608 Added 143.97%	23,060 $3.93 Million
Q3 2020 Nov 16, 2020	SELL	$127.12 - $172.34 $6.13 Million - $8.31 Million	-48,216 Reduced 83.61%	9,452 $1.33 Million
Q2 2020 Aug 14, 2020	BUY	$93.0 - $171.7 $2.47 Million - $4.57 Million	26,608 Added 85.67%	57,668 $9.25 Million
Q1 2020 May 15, 2020	BUY	$82.38 - $131.64 $2.24 Million - $3.58 Million	27,228 Added 710.54%	31,060 $3.04 Million
Q4 2019 Feb 14, 2020	SELL	$76.53 - $135.58 $4.63 Million - $8.21 Million	-60,563 Reduced 94.05%	3,832 $494,000
Q2 2019 Aug 14, 2019	SELL	$112.21 - $151.95 $6.53 Million - $8.85 Million	-58,236 Reduced 47.49%	64,395 $9.79 Million
Q3 2018 Nov 14, 2018	SELL	$115.31 - $161.51 $33.6 Million - $47.1 Million	-291,710 Reduced 70.4%	122,631 $19.8 Million
Q2 2018 Aug 14, 2018	BUY	$71.74 - $153.69 $29.1 Million - $62.4 Million	406,264 Added 5029.89%	414,341 $54.8 Million
Q1 2018 May 15, 2018	SELL	$54.02 - $82.27 $9.02 Million - $13.7 Million	-166,998 Reduced 95.39%	8,077 $598,000
Q4 2017 Feb 14, 2018	BUY	$47.64 - $56.75 $2.83 Million - $3.37 Million	59,384 Added 51.33%	175,075 $9.74 Million
Q3 2017 Nov 14, 2017	BUY	$35.73 - $47.15 $4.13 Million - $5.45 Million	115,691	115,691 $5.25 Million

Others Institutions Holding SRPT

# of Institutions

470

Shares Held

79.3M

Call Options Held

4.23M

Put Options Held

1.21M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $13.3B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account